About the author

From the following article:

Radiotherapy plus adjuvant temozolomide for the treatment of glioblastoma—a paradigm shift

Howard A Fine

Nature Clinical Practice Oncology (2005) 2, 334-335
doi:10.1038/ncponc0204

BACK TO ARTICLE

Howard A Fine

 

HA Fine is the Chief of the Neuro-Oncology Branch at the National Cancer Institute, Bethesda, MD, USA.

BACK TO ARTICLE